No price history available.
Key financial summary
Financials in JPY| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM | 2026E | ||
|---|---|---|---|---|---|---|---|---|---|
| Total revenue | ¥m | 52,430 | 54,398 | 58,578 | 59,151 | 60,561 | 61,769 | N/A | N/A |
| Operating profit | ¥m | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Net profit | ¥m | 2,295 | 2,557 | 2,702 | 3,134 | 2,946 | 2,746 | N/A | N/A |
| EPS reported | ¥ | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Operating cashflow per share | ¥ | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Capex per share | ¥ | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| FCF per share | ¥ | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Free cash flow | ¥m | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Net debt | ¥m | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Book value equity | ¥m | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Book value per share | ¥ | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Number of shares | m | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| DPS (TTM paid) | ¥ | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
Financial summary
Financials in JPY| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM | 2026E | ||
|---|---|---|---|---|---|---|---|---|---|
| Value | |||||||||
| P/E LTM | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| P/B LTM | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| P/S LTM | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| P/FCF LTM | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| EV/EBITDA LTM | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| EV/Sales LTM | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Earnings Yield LTM | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| FCF Yield | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Quality | |||||||||
| ROE | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| ROIC | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Operating margin | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Gross margin | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| FCF/Sales | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Growth and momentum | |||||||||
| EPS Growth YoY | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Sales Growth YoY | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Net Income Growth YoY | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| FCF Growth | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Operating Profit Growth | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Dividend and capital structure | |||||||||
| Dividend Yield | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Dividend Growth | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Payout Ratio | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| FCF/Debt | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Net Debt/EBITDA | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| EBIT/Net interest | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Net debt/market cap | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Net debt/Equity | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Gross debt/equity | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
Ratings
Based on consensus from external analysts. Not Kvantra's opinion.
Company overview
France Bed Holdings Co.,Ltd., through its subsidiaries, engages in the medical services and home furnishing and health businesses in Japan. It operates through the Medical Services Business and Home Furnishings and Health Business segments. The company is involved in the development and proposal of products for facilities, such as monitoring and nursing care robots; and manufacture, purchase, rental, retail, and wholesale of nursing care products and welfare equipment such as multi-fit beds, handrails, and multi-position beds, as well as health support products. It also offers linen supply for medical and welfare facilities and hotels; consultations, including nursing care consultations and care plan creation; and electrical stimulation rehabilitation equipment that can be used at home and in medical settings. In addition, the company engages in the operation of showrooms and PR studios; provision of sofas, sofa beds, and bed-type massagers; exhibition sales of furniture, and fashion and jewelry; in-home long-term care support business, long-term care business for residents of specified facilities, dementia-friendly communal living long-term care, small-scale multifunctional in-home care, outpatient care, rental housing for the elderly; and design and construction of guest rooms and lobbies, as well as interior coordination. It offers its products through a range of sales channels, including furniture stores, department stores, interior shops, and hotels. France Bed Holdings Co.,Ltd. was incorporated in 2004 and is based in Tokyo, Japan.
Similar companies
For informational purposes only. Kvantra provides data and quantitative analysis, not investment advice. KvantraRank is a mechanical model output. Analyst price targets and ratings are sourced from third parties and are not Kvantra recommendations. Past performance does not guarantee future results; all investments carry risk.
France Bed Holdings Co., Ltd. (7840.T)
No price history available.
Not enough data to calculate KvantraRank
Based on consensus from external analysts. Not Kvantra's opinion.
France Bed Holdings Co.,Ltd., through its subsidiaries, engages in the medical services and home furnishing and health businesses in Japan. It operates through the Medical Services Business and Home Furnishings and Health Business segments. The company is involved in the development and proposal of products for facilities, such as monitoring and nursing care robots; and manufacture, purchase, rental, retail, and wholesale of nursing care products and welfare equipment such as multi-fit beds, handrails, and multi-position beds, as well as health support products. It also offers linen supply for medical and welfare facilities and hotels; consultations, including nursing care consultations and care plan creation; and electrical stimulation rehabilitation equipment that can be used at home and in medical settings. In addition, the company engages in the operation of showrooms and PR studios; provision of sofas, sofa beds, and bed-type massagers; exhibition sales of furniture, and fashion and jewelry; in-home long-term care support business, long-term care business for residents of specified facilities, dementia-friendly communal living long-term care, small-scale multifunctional in-home care, outpatient care, rental housing for the elderly; and design and construction of guest rooms and lobbies, as well as interior coordination. It offers its products through a range of sales channels, including furniture stores, department stores, interior shops, and hotels. France Bed Holdings Co.,Ltd. was incorporated in 2004 and is based in Tokyo, Japan.
